Clinical Trial Update: Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study [Phase 2]

View source ↗

Summary

Phase 2 trial update on oral desensitization to peanut in peanut-allergic children and adults using CPNA peanut OIT safety follow-on study; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• CPNA peanut OIT (peanut oral immunotherapy)

Snippet

Sponsor: Aimmune Therapeutics, Inc. | Conditions: Peanut Allergy | Phase 2 | Status: COMPLETED | Results posted: 2021-11-09